Lite Strategy (LITS) Interest Coverage Ratio (2011 - 2020)
Lite Strategy (LITS) posted Interest Coverage Ratio of 2556.4 for Q3 2020, down 183.53% on a QoQ basis from 901.64 in Q3 2019, and down 183.53% year-over-year from 3060.57 in Q4 2019.
Analysis
Lite Strategy (LITS) Interest Coverage Ratio (2011 - 2020) Analysis & Trends
Lite Strategy has reported Interest Coverage Ratio for 4 years, with the latest figure at 2556.4 in Q3 2020.
- On a quarterly basis, Interest Coverage Ratio fell 183.53% year-over-year to 2556.4 in Q3 2020; TTM through Sep 2020 was 1292.8, a 60.29% increase from a year earlier, with the FY2012 full-year figure at 20.67, changed N/A from the prior year.
- Interest Coverage Ratio was 2556.4 for Q3 2020 at Lite Strategy, down from 901.64 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 901.64 in Q3 2019, with the low at 10033.0 in Q3 2018.
- Average Interest Coverage Ratio over 3 years is 4497.01, with a median of 2556.4 recorded in 2020.
- The sharpest annual moves came in 2019 and 2020: Interest Coverage Ratio soared 91.01% in 2019, then tumbled 183.53% in 2020.
- Over 3 years, Interest Coverage Ratio stood at 10033.0 in 2018, then jumped by 91.01% to 901.64 in 2019, then slumped by 183.53% to 2556.4 in 2020.
- The last three Interest Coverage Ratio figures came in at 2556.4 (Q3 2020), 901.64 (Q3 2019), and 10033.0 (Q3 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | -2,556.40 |
| Sep 30, 2019 | -901.64 |
| Sep 30, 2018 | -10,033.00 |
| Dec 31, 2011 | -217.44 |
| Sep 30, 2011 | -4.87 |